Ticker Symbol: AXDX
Accelerate Diagnostics Inc
$6.12 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000727207
Company Profile
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3826
Address: 3950 S Country Club Rd Ste 470 Bldg 3-307
Website: http://acceleratediagnostics.com/
CEO: John Phillips
Tags:
- Health Technology
- Biotechnology
- Medical Specialties
- Manufacturing
- Analytical Laboratory Instrument Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $6.08
Change:
$0.39
(
6.85%)
Days Range: $5.52 - $6.20
Beta: 1.16
52wk. High: $16.25
52wk. Low: $4.50
Ytd. Change -7.03%
50 Day Moving Average: $6.14
200 Day Moving Average: $7.02
Shares Outstanding: 14367971
Valuation
Market Cap: 8.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A